Clues to novel treatments could be gleaned from people who aren’t sick, but should be.
The attempt is another controversial test of whether gene-modified people are possible.
A genetic technology that can kill off mosquito species could eradicate malaria. But is it too risky to ever use?
A government investigation of Theranos’s lab has documented a host of troubles at the blood-testing startup.
The first gene therapy approved in the Western world costs $1 million and has been used just once. The doctor who tried it says the price is “absolutely too high.”
How one nonprofit’s mailroom is making tinkering with genomes as easy as shopping at Amazon.
U.S. and Finnish doctors caught the brain-shrinking virus in action and say tests to screen for such problems are possible.
A portable assembly line for medicines offers a better way to respond to outbreaks and shortages.
Beth Stevens thinks she has solved a mystery behind brain disorders such as Alzheimer’s and schizophrenia.
Another chance to catch the most interesting, and important, articles from the previous week on MIT Technology Review.